Clients
|
|
|
Acceleron Pharma is a privately held biopharmaceutical company committed to discover, develop, manufacture and commercialize novel biotherapeutics that modulate the growth of red blood cells, bone, muscle, fat and the vasculature to treat musculoskeletal, metabolic and cancer-related diseases. |
Acorda Therapeutics is a biotechnology company developing therapies for spinal cord injury, multiple sclerosis and related nervous system disorders. |
|
|
|
Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients' lives. |
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi, to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies, the current major classes of drugs. |
|
|
|
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. |
BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for three clinical indications: Dupuytren's disease; Peyronie's disease; and frozen shoulder (adhesive capsulitis). |
|
|
|
Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new medicines for cancer indications. |
Endocyte is a privately held biotechnology company working to develop new drugs and diagnostic agents to treat many types of cancer and other serious diseases based on the applications of its advanced proprietary guided drug technology. |
|
|
|
ImmunoGen, Inc. develops targeted anticancer therapeutics using its expertise in cancer biology, monoclonal antibodies and the creation and attachment of potent cell-killing agents. |
Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. |
|
|
|
Millennium: The Takeda Oncology Company, a leading biopharmaceutical company, markets a first-in-class proteasome inhibitor, and has a robust clinical development pipeline of product candidates. |
Momenta Pharmaceuticals is a biotechnology company specializing in the detailed structural analysis of complex mixture drugs, which it is applying to the development of generic versions of complex drug products, as well as to the discovery and development of novel drugs. |
|
|
|
Rexahn Pharmaceuticals is a clinical stage pharmaceutical company dedicated to commercializing first in class and market leading therapeutics for cancer, CNS disorders, sexual dysfunction and other unmet medical needs. |
SciClone Pharmaceuticals, Inc. is a profit-driven, global biopharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. |
|
|
|
SkinMedica is a privately held company focused on developing, acquiring and commercializing products that treat dermatologic conditions and improve the appearance of skin. SkinMedica markets and sells, primarily to dermatologists, both prescription pharmaceutical products and physician-dispensed, non-prescription skin care products. |
Tengion is a clinical stage company focused on discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues. These functional neo-organs and neo-tissues are currently created using a patient’s own cells, or autologous cells, in conjunction with the company’s Organ Regeneration Platform. |
|
|
|
Verenium Corporation is a leader in the development and commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as high-performance specialty enzymes for applications within the biofuels, industrial, and animal health markets. |